• AstraZeneca average return on equity for 2023 was 15.48, a 662.56% increase from 2022.
• AstraZeneca average return on equity for 2022 was 2.03, a 86.56% increase from 2021.
• AstraZeneca average return on equity for 2021 was 15.1, a 11.8% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.